Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

nhow Brussels Bloom

Nov 30, 2022 2:00 PM - Nov 30, 2022 10:30 PM

Rue Royale 250, 1210 Brussels, Belgium

Innovative Therapies in Europe

DIA-EUCOPE Workshop: 5 Years of ATMPs on the Market - Lessons Learned

Session 2: Is Zynteglo representative for the ATMPs failure in Europe? Are EU systems broken for innovative therapies?

Session Chair(s)

Alexander  Natz, JD

Alexander Natz, JD

Secretary General

European Confederation of Pharmaceutical Entrepreneurs, Belgium

Topics covered in this session include:

  • Case study & domino effect
  • The regulatory aspects
  • Historical background for withdrawals


Sophie  Schmitz

Sophie Schmitz

Sophie Schmitz

P4A Partners for Access, Netherlands

Managing Partner

Oswald  Bentinck

The Zolgensma Experience – Can one-time ATMP’s be successfully commercialized in Europe?

Oswald Bentinck

Rocket Pharmaceuticals, Inc., United States

Vice President, Global Head of Value & Access

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.